Polianta LTD Horizon Therapeutics Public LTD CO Transaction History

Polianta LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 07, 2020	SELL	$24.87 - $38.56 $833,145 - $1.29 Million	-33,500 Closed	0 $0
Q4 2019 Jan 13, 2020	SELL	$25.43 - $36.67 $386,536 - $557,384	-15,200 Reduced 31.21%	33,500 $1.21 Million
Q3 2019 Oct 09, 2019	BUY	$23.0 - $27.97 $223,100 - $271,309	9,700 Added 24.87%	48,700 $1.33 Million
Q2 2019 Jul 17, 2019	BUY	$22.81 - $28.48 $889,590 - $1.11 Million	39,000 New	39,000 $938,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

Stay updated on Polianta LTD with notifications on news.